Advanced Therapies Congress 2024

The event unites ATMP-players (ATMP = advanced therapy medicinal products) across the world, to give insight and to promote collaboration to accelerate the development and commercialization of next generation medicines. More than 2,500 attendees from pharma, biotech, research, regulatory bodies, HTAs investment and start-ups are expected to focus on 300 speakers in various topic tracks like pricing and market access, gene therapies or rare diseases. In the startup zone, ATMP start-up companies are presenting their work on cutting edge cell and gene therapies, innovative platform technologies and pioneering AI and machine learning solutions.

Join our market access manager, Dr. Lara Schröder, together with Dr. Alexander Natz and Thomas Bols on the exciting panel discussion "Finding the right framework for reimbursement and market access" at the Evidence, Pricing and Access track (Tuesday, 4.30pm). 

Our market access managers PD Dr. Sabrina Schlie-Wolter and Dr. Lara Schröder are looking forward to representing SKC at the event and to exploring the latest topics in ATMPs.

Are you participating at the congress as well? Please do not hesitate to contact us and arrange a personal meeting.

Sources:
Terrapinn: Advanced Therapies Congress